MaxCyte Share News (MXCT)
MXCT Share
MXCT Share
MXCT Share
MXCT Share
MXCT
MXCT Share
MXCT Level 2
MXCT Live
MXCT Broker
MXCT Directors
MXCT Financial
MXCT
MXCT Short
MXCT
Last checked at -
(Sharecast News) - Cell engineering company MaxCyte reported record quarterly revenue of $10.2m (£7.73m) for the final three months of 2021 on Wednesday, up 19% year-on-year.
Read more
| Wednesday 16 March | |
| 4imprint Group PLC | Full Year Results |
| Advanced Medical Solutions Group PLC | Full Year Results |
| Centamin PLC | Full Year Results |
| Centaur Media PLC | Full Year Results |
| CLS Holdings PLC | Full Year Results |
| Computacenter PLC | Full Year Results |
| Eagle Eye Solutions Group PLC | Half Year Results |
| Fevertree Drinks PLC | Full Year Results |
| Gelion PLC | Half Year Results |
| Gym Group PLC | Full Year Results |
| LSL Property Services PLC | Full Year Results |
| PensionBee Group PLC | Full Year Results |
| Pharos Energy PLC | Full Year Results |
| Restaurant Group PLC | Full Year Results |
| Restore PLC | Full Year Results |
| RPS Group PLC | Full Year Results |
| Science Group PLC | Full Year Results |
| Thursday 17 March | |
| Ceres Power Holdings PLC | Full Year Results |
| Cineworld Group PLC | Full Year Results |
| Deliveroo PLC | Full Year Results |
| Emis Group PLC | Full Year Results |
| Empresaria Group PLC | Full Year Results |
| FDM Group PLC | Full Year Results |
| Gem Diamonds Ltd | Full Year Results |
| Harbour Energy PLC | Full Year Results |
| Helios Towers PLC | Full Year Results |
| Marshalls PLC | Full Year Results |
| Mpac Group PLC | Full Year Results |
| Ocado Group PLC | Q1 Results |
| PensionBee Group PLC | Full Year Results |
| Trainline PLC | Trading Statement |
| TransGlobe Energy Corp | Full Year Results |
| Tribal Group PLC | Full Year Results |
| Wickes Group PLC | Full Year Results |
| Friday 18 March | |
| ContourGlobal PLC | Full Year Results |
| Essentra PLC | Full Year Results |
| Eurocell PLC | Full Year Results |
| Investec PLC | Trading Statement |
| J D Wetherspoon PLC | Half Year Results |
| S4 Capital PLC | Full Year Results |
| Monday 21 March | |
| Photo-Me International PLC | Full Year Results |
| Spectral MD Holdings Ltd | Full Year Results |
| Sthree PLC | Trading Statement |
| Tuesday 22 March | |
| Alliance Pharma PLC | Full Year Results |
| BioPharma Credit PLC | Full Year Results |
| Circassia Group PLC | Full Year Results |
| Diaceutics PLC | Full Year Results |
| Diurnal Group PLC | Full Year Results |
| IQGeo Group PLC | Full Year Results |
| Longboat Energy PLC | Full Year Results |
| Luceco PLC | Full Year Results |
| MaxCyte Inc | Full Year Results |
| MP Evans Group PLC | Full Year Results |
| Oxford Nanopore Technologies PLC | Full Year Results |
| Pebble Group PLC | Full Year Results |
| Real Estate Investors PLC | Full Year Results |
| Sabre Insurance Group PLC | Full Year Results |
| ScS Group PLC | Half Year Results |
| Softcat PLC | Half Year Results |
| Staffline Group PLC | Full Year Results |
| Trustpilot Group PLC | Full Year Results |
| YouGov PLC | Half Year Results |
| Zotefoams PLC | Full Year Results |
| Copyright 2022 Alliance News Limited. All Rights Reserved. | |
MaxCyte Inc - Maryland-based platform for cell-based research - Hires Cenk Sumen as chief scientific officer. Sumen joins from San Diego, California-based hair-loss treatment firm Stemson Therapeutics Corp, where he was chief technology officer.
Read more(Sharecast News) - Cell engineering company MaxCyte announced the appointment of Cenk Sumen as its chief scientific officer on Thursday.
Read more(Sharecast News) - Cell engineering technology company MaxCyte announced the consolidation of the two lines of its common stock into a single unrestricted line of common stock on Monday.
Read more(Sharecast News) - Cell engineering platform technology company MaxCyte announced the signing of a strategic platform licence (SPL) with Intima Bioscience on Tuesday.
Read moreMaxCyte signs strategic platform pact with Intima Bioscience
Read moreMaxCyte expects improved full-year revenue on organic growth
Read more(Sharecast News) - Cell engineering company MaxCyte said on Monday that it expected total revenue for its fourth quarter to be at least $10m, up from $8.5m year-on-year, reflecting growth of at least 17% in total revenue and at least 37% in core business revenue.
Read moreUK earnings, trading statements calendar - next 7 days
Read moreDIRECTOR DEALINGS: New MaxCyte chair buys USD220,000 in shares
Read more(Sharecast News) - Maxcyte revealed on Tuesday that chairman Richard Douglas had acquired 20,000 ordinary shares in the AIM-listed cell-engineering company.
Read moreTRADING UPDATES: iEnergizer and Volex post interim profit hikes
Read more(Sharecast News) - Commercial cell engineering company MaxCyte reported total third quarter revenue of $10.1m in an update on Thursday, representing 50% growth compared to the same period in 2020.
Read moreEXECUTIVE CHANGES: MaxCyte promotes to chair; Sanderson adds retailers
Read more
Last checked at